FGF-dependent metabolic control of vascular development

Pengchun Yu, Kerstin Wilhelm, Alexandre Dubrac, +19

Nature

Developmental BiologyAngiogenesisVascular AdaptationPhysiologyVascular Endothelial Growth Factor +6

Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis

Pei‐Yu Chen, Lingfeng Qin, Guangxin Li, +24

Nature Metabolism

InflammationVascular DiseaseCardiovascular DiseaseImmunologyEndothelial Dysfunction +6

Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia

Benshang Li, Samuel W. Brady, Xiaotu Ma, +44

Blood

Smooth Muscle Cell Reprogramming in Aortic Aneurysms

Pei-Yu Chen, Lingfeng Qin, Guangxin Li, +22

Cell stem cell

MechanobiologyCardiac ReprogrammingVascular AdaptationVascular BiologyAortic Aneurysms +4

Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer

Yang Shu, Weihan Zhang, Qianqian Hou, +45

Nature Communications

What are the roles of green technology innovation and ICT employment in lowering carbon intensity in China? A city-level analysis of the spatial effects

Hongye Sun

Resources Conservation and Recycling

Green GrowthEngineeringGreen Technology InnovationGreen IctGreen City +8

HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib

Douglas D. Fang, Bin Zhang, Qingyang Gu, +15

Journal of Thoracic Oncology

Medicinal ChemistryReceptor Tyrosine KinaseSystems BiologyMedicineCell Biology +2

The composite impact of ICT industry on lowering carbon intensity: From the perspective of regional heterogeneity

Hongye Sun, Giseung Kim

Technology in Society

ProductivityEconomicsCarbon Emission TradingEngineeringComposite Impact +11

Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development

Qingyang Gu, Bin Zhang, Hongye Sun, +18

Oncotarget

Activating <i>JAK1</i> mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma

Shuqun Yang, Chonglin Luo, Qingyang Gu, +13

Oncotarget